0.10AUD
9.97 MAUD
146.61 MAUD
26.82 M
About AFT PHARMACEUTICALS LIMITED
Sector
CEO
Hartley Atkinson
Headquarters
Auckland
Website
Employees (FY)
100
Founded
1997
ISIN
NZAFTE0001S4
FIGI
BBG00BQXDKK3
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AFP is 2.83 AUD — it has increased by 4.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AFT PHARMACEUTICALS LIMITED stocks are traded under the ticker AFP.
AFT PHARMACEUTICALS LIMITED is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
AFP stock is 4.24% volatile and has beta coefficient of −0.20. Check out the list of the most volatile stocks — is AFT PHARMACEUTICALS LIMITED there?
One year price forecast for AFT PHARMACEUTICALS LIMITED has a max estimate of 4.31 AUD and a min estimate of 2.63 AUD.
AFP earnings for the last quarter are 0.01 AUD per share, whereas the estimation was 0.35 AUD resulting in a −97.50% surprise. The estimated earnings for the next quarter are 0.03 AUD per share. See more details about AFT PHARMACEUTICALS LIMITED earnings.
AFT PHARMACEUTICALS LIMITED revenue for the last quarter amounts to 57.50 M AUD despite the estimated figure of 48.50 M AUD. In the next quarter revenue is expected to reach 75.05 M AUD.
Yes, you can track AFT PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
AFP stock has fallen by 0.70% compared to the previous week, the month change is a 5.03% fall, over the last year AFT PHARMACEUTICALS LIMITED has showed a 10.44% decrease.
AFP net income for the last quarter is 1.69 M AUD, while the quarter before that showed 8.61 M AUD of net income which accounts for −80.35% change. Track more AFT PHARMACEUTICALS LIMITED financial stats to get the full picture.
Today AFT PHARMACEUTICALS LIMITED has the market capitalization of 294.97 M, it has increased by 0.68% over the last week.
Yes, AFP dividends are paid annually. The last dividend per share was 0.01 AUD. As of today, Dividend Yield (TTM)% is 0.36%. Tracking AFT PHARMACEUTICALS LIMITED dividends might help you take more informed decisions.
AFT PHARMACEUTICALS LIMITED dividend yield was 0.32% in 2022, and payout ratio reached 10.83%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AFP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AFT PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 100.00 employees. See our rating of the largest employees — is AFT PHARMACEUTICALS LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AFT PHARMACEUTICALS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AFT PHARMACEUTICALS LIMITED stock shows the sell signal. See more of AFT PHARMACEUTICALS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AFT PHARMACEUTICALS LIMITED future price: according to them, AFP price has a max estimate of 4.31 AUD and a min estimate of 2.63 AUD. Read a more detailed AFT PHARMACEUTICALS LIMITED forecast: see what analysts think of AFT PHARMACEUTICALS LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AFT PHARMACEUTICALS LIMITED EBITDA is 19.50 M AUD, and current EBITDA margin is 13.66%. See more stats in AFT PHARMACEUTICALS LIMITED financial statements.